SAN FRANCISCO and SUZHOU, China, Oct. 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other...
Hence then, the article about innovent announces nmpa acceptance of a new indication application of sintilimab for the treatment of advanced melanoma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma )
Also on site :
- James Gunn Defends the DC Universe, Says He Dislikes the Idea That ‘Individual Stories Aren’t Meaningful Unless They Lead to Something’
- Detroit Lions Broadcaster Dan Miller Honors Late Wife During First Game Back, and What Happens Next Is Enough to Bring You to Tears
- China Box Office: ‘Resident Evil’ Stays at No. 1 as Market Hits Fall Lull